This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moris G, Carcia-Monco JC . The challenge of drug-induced aseptic meningitis Arch Intern Med 1999 159: 1185–1194
Flasshove M, Schütte HJ, Kellner R, Höffken, Seeber S . Meningeal fluid granulocytosis after cytarabine Eur J Cancer 1992 28: 243
Thordarson H, Talstad I . Acute meningitis and cerebellar dysfuncion complicating high-dose cytosine arabinoside therapy Acta Med Scand 1986 220: 493–495
Wolff L, Zighelboim J, Gale RP . Paraplegia following intrathecal cytosine arabinoside Cancer 1979 43: 83–85
Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, Pico JL . Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults Baillières Clin Haematol 1994 7: 339–348
Herzig RH, Herzig GP, Wolff SN, Hines JD, Fay JW, Phillips GL . Central nervous system effects of high-dose cytosine arabinoside Semin Oncol 1987 14: (Suppl. 1) 21–24
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van den Berg, H., van der Flier, M. & van de Wetering, M. Cytarabine-induced aseptic meningitis. Leukemia 15, 697–699 (2001). https://doi.org/10.1038/sj.leu.2402063
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402063
This article is cited by
-
Neurotoxicity of chemotherapeutic and biologic agents in children with cancer
Current Neurology and Neuroscience Reports (2008)
-
Nebenwirkungen der Therapie von Hirntumoren
Der Onkologe (2006)